Sumitomo Dainippon, Hitachi, Kyoto University deal

Sumitomo, the university’s center for induced pluripotent stem (iPS) cell research and application (CiRA) and Hitachi partnered to develop a treatment for Parkinson’s disease (PD) using iPS cells. The partners will establish a mass production process for dopaminergic neural progenitor cells. ...